AGP Executive Report
Last update: 12 hours agoBiotech: New Haven-based Arvinas will present preliminary Phase 1 data on its experimental lymphoma drug at December’s American Society of Hematology meeting, including early safety findings and results from patients with T-cell lymphomas. AI Rules: Connecticut’s new AI law sets requirements for employers using automated tools in decisions such as hiring, promotion and discipline, and for developers of those systems. Quantum Computing: IonQ has secured a QuantumCT contract for more than 150 hours of cloud quantum-computing access, widening opportunities to use the technology. Cybersecurity: Connecticut is launching support for defense contractors to strengthen cyber protections across the state’s defense industry.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.